Friday Briefing

California legal showdown highlights efforts to clean up high-carbon fuels. The state’s ground-breaking plan to require oil importers and refiners to cut the “carbon intensity” of their transportation fuels is being delayed by a court injunction won by the oil industry.  Eleven other states and the European Union are working on similar rules, which could influence demand for carbon-intensive Canadian oil. InsideClimate News

Johnson & Johnson will pay $158 million to settle a Texas lawsuit over its marketing of the antipsychotic drug Risperdal. The lawsuit accused the company of bilking the state’s Medicaid program for the poor by pushing sales of Risperdal for unapproved uses on children and others. Earlier this month the company said it would spend more than $1 billion to settle civil investigations by federal and state authorities around the country. Reuters

Federal authorities will deliver water to four households in Dimock, Pa., near natural gas wells. The Environmental Protection Agency also will sample water at 61 homes in the rural community to assess “whether any residents are being exposed to hazardous substances that cause health concerns.” The EPA announcement is the latest turn in its on-again, off-again intervention in Dimock, where state officials three years ago blamed drilling by Cabot Oil & Gas Corp. for contaminating water wells of 19 homes. The Philadelphia Inquirer, EPA

European regulators order urgent inspections on Airbus A380 aircraft, the world’s largest jetliners. Authorities acted after Airbus disclosed two sets of cracks on its A380 superjumbos just two weeks apart, and barely four years after the 525-seat passenger jet entered service. No jets have been grounded but inspections must be carried out within six weeks for most of the 22 aircraft, one-third of the Airbus 380 fleet, placed on a check-up list. Reuters

Carnival Corp. to review safety and emergency response procedures on all of its 10 cruise lines.  The company’s announcement stems from last Friday’s Costa Concordia accident off the west coast of Italy. At least 11 are dead, and about 20 people remain missing. The Associated Press, Bloomberg

Experts likely to narrow definition of autism. Proposed changes, under review by a panel advising the American Psychiatric Association, could make it harder for many people who would no longer meet the criteria to get health, educational and social services benefits. The New York Times

Idaho accident that exposed 16 workers to plutonium radiation could have been prevented, report says. A U.S. Energy Department assessment blamed poor training and other safety shortcomings in the November incident at the Idaho National Laboratory. It still hasn’t been determined how much radiation the workers were exposed to when radioactive powder spilled out of a container. The Associated Press

Skin-lightening creams from Mexico blamed for mercury exposure. Public health authorities in California and Virgina warned consumers against using the creams, based on an investigation linking the product to elevated blood mercury levels. Mercury exposure can cause renal and nervous system damage, and is potentially fatal. Consumer Reports, Centers for Disease Control and Prevention

Recalls: Kia Optima and Rondo vehicles with possible air bag flaws, Winn-Dixie expands Leasa sprouts recall, Vagifresh and Female One cosmetics, Nicolet neurological monitoring devices

Compiled by Stuart Silverstein

Print Print  

One comment to “Friday Briefing”

  1. Daniel Haszard

    Risperal reproached.
    Same saga here as Eli Lilly Zyprexa.

    Johnson and Johnson is a trusted brand we associate with babies.
    Risperdal,Zyprexa,as well as the other atypical antipsychotics, are being prescribed for children, even though this is an unapproved, off-label use. An estimated 2.5 million children are now taking atypical antipsychotics. Over half are being given them for Attention Deficit Hyperactivity Disorder,many of these foster children.
    Weight gain, increases in triglyceride levels and associated risks for (life-long) diabetes and cardiovascular disease.
    Lilly made $65 billion on Zyprexa!
    –Daniel Haszard
    *Tell the truth don’t be afraid*

Leave a comment